PI Industries Q2 Profit Plummets 70% to Rs 122 Crore

Revenue from operations for the quarter stood at Rs 1,701.8 crore, compared to Rs 1,872.3 crore in Q2 FY26.

Reader Takeaway: Declining Agro Chemicals performance weighed on the bottom line, though Pharma segment losses showed some improvement.

What just happened

PI Industries released its consolidated financial results for the quarter ended September 30, 2026, showing a sharp contraction in earnings. Consolidated net profit for Q2 FY27 dropped to Rs 122.2 crore, a substantial decline from the Rs 409.3 crore reported in the same quarter last year. Revenue for the period decreased by roughly 9% year-on-year, landing at Rs 1,701.8 crore.

Why this matters

The Agro Chemicals business, which serves as the primary revenue engine for the firm, saw its results under pressure during the quarter. Segment profit before tax for Agro Chemicals fell to Rs 247.3 crore from Rs 590.7 crore in the previous year. This segment's performance is critical for investors, as it dictates the company's overall health and ability to maintain margins.

What changes now

The company continues to scale its Pharma segment, which reported revenue of Rs 75.9 crore in Q2 FY27 against Rs 63.4 crore a year ago. Notably, the Pharma segment reduced its operating loss to Rs 60.7 crore, compared to a loss of Rs 81.9 crore in Q2 FY26. Management will now face increased scrutiny regarding demand cycles in the agro-chemical space and how quickly the pharma vertical can achieve profitability.

What to track next

Investors should monitor management commentary regarding margin sustainability and the recovery timeline for the agro-chemical division. Additionally, watch for updates on the capital expenditure and scaling progress of the Pharma business, which remains a long-term growth driver.